Cargando…

Acknowledgment to the Reviewers of Pharmaceuticals in 2022

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965351/
http://dx.doi.org/10.3390/ph16020137
_version_ 1784896741344018432
collection PubMed
description
format Online
Article
Text
id pubmed-9965351
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99653512023-02-26 Acknowledgment to the Reviewers of Pharmaceuticals in 2022 Pharmaceuticals (Basel) Editorial MDPI 2023-01-17 /pmc/articles/PMC9965351/ http://dx.doi.org/10.3390/ph16020137 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Acknowledgment to the Reviewers of Pharmaceuticals in 2022
title Acknowledgment to the Reviewers of Pharmaceuticals in 2022
title_full Acknowledgment to the Reviewers of Pharmaceuticals in 2022
title_fullStr Acknowledgment to the Reviewers of Pharmaceuticals in 2022
title_full_unstemmed Acknowledgment to the Reviewers of Pharmaceuticals in 2022
title_short Acknowledgment to the Reviewers of Pharmaceuticals in 2022
title_sort acknowledgment to the reviewers of pharmaceuticals in 2022
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965351/
http://dx.doi.org/10.3390/ph16020137
work_keys_str_mv AT acknowledgmenttothereviewersofpharmaceuticalsin2022